Explorer les evidences

Palier Gold : evidences validées mécaniquement, avec leur source primaire.

15 evidences · page 1 / 1

89 %In 2019, first-dose HPV vaccination coverage was estimated at 89% and second-dose coverage at 25% in Senegal.

Sénégalinfection à HPVobservé 2019HAL · Unilimdocument de 111 observations

47 %For the period 2022–2024, HPV first-dose vaccination coverage was assumed to be 47% and second-dose coverage 25% in Senegal.

Sénégalinfection à HPVobservé 2022–2024HAL · Unilimdocument de 111 observations

65 %In 2021, HPV vaccine first-dose coverage in Senegal was 65%.

Sénégalinfection à HPVobservé 2021HAL · Unilimdocument de 111 observations

47 %In 2020, HPV vaccine first-dose coverage in Senegal was 47%.

Sénégalinfection à HPVobservé 2020HAL · Unilimdocument de 111 observations

11 232 dosesThe school-based HPV vaccine demonstration project administered a total of 11,232 doses.

Sénégalinfection à HPVobservé 2014 to 2016HAL · Unilimdocument de 111 observations

31,75 %After rescaling to fit within a 100% envelope, the most prevalent HPV types in Senegal were type 16 (31.75%), type 18 (26.35%), type 45 (10.48%), and type 33 (9.84%).

Sénégalinfection à HPVHAL · Unilimdocument de 111 observations

47 %In 2020, first-dose HPV vaccination coverage declined to 47% and second-dose coverage to 32% in Senegal.

Sénégalinfection à HPVobservé 2020HAL · Unilimdocument de 111 observations

7 strategiesSeven HPV vaccination strategies were identified along the cost-effectiveness frontier.

Sénégalinfection à HPVHAL · Unilimdocument de 111 observations

25 %In 2019, only 25% of eligible girls in Senegal completed the second dose of HPV vaccine.

Sénégalinfection à HPVobservé 2019HAL · Unilimdocument de 111 observations

70 %In the base-case analysis, a single dose of the HPV vaccine was assumed to provide 70% to 100% of the total efficacy associated with two doses.

Sénégalinfection à HPVHAL · Unilimdocument de 111 observations

100 %The most common HPV types identified in a cervical cancer surveillance study in Senegal between 2013 and 2017 were type 16 (100%), type 18 (83%), and type 45 (33%).

Sénégalcancer du col de l'utérus · infection à HPVobservé 2013–2017HAL · Unilimdocument de 111 observations

32 %In 2020, HPV vaccine second-dose coverage in Senegal was 32%.

Sénégalinfection à HPVobservé 2020HAL · Unilimdocument de 111 observations

90 %The school-based HPV vaccine demonstration project in Dakar Ouest and Meckhe districts achieved 90% administrative coverage among nine-year-old girls.

Sénégalinfection à HPVobservé 2014 to 2016HAL · Unilimdocument de 111 observations

89 %In 2019, 89% of eligible girls in Senegal received the first dose of HPV vaccine.

Sénégalinfection à HPVobservé 2019HAL · Unilimdocument de 111 observations

80 %In the base-case analysis, a single dose of the HPV vaccine was assumed to provide 80% of the total efficacy associated with two doses.

Sénégalinfection à HPVHAL · Unilimdocument de 111 observations

Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.